Insulin Lispro Injection, Solution
Product Images NDC 50090-5391

Product Visual Gallery

This gallery contains 54 technical images submitted to the FDA as part of the official labeling for Insulin Lispro (NDC 50090-5391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905391)

Insulin Lispro injection solution label for 10 mL vial from A-S Medication Solutions. The label specifies 100 units per mL concentration and instructs refrigeration without freezing. It includes product and lot numbers, and a QR code linking to dosing information.*

FDA Label Image

Primary Structure (Lispro Chem V1)

Chemical structure diagram of Insulin Lispro showing the amino acid sequences and disulfide bonds linking the A-Chain and B-Chain of the insulin molecule.*

FDA Label Image

Figure (Lispro Clock V1)

An illustration of a stopwatch showing a 5-second countdown, likely indicating a timing instruction related to the use of the drug Insulin Lispro injection solution.*

FDA Label Image

Figure (Lispro Ifu Peel V1)

An instructional illustration showing a hand removing a cap from a vial or container by lifting it upward with a twisting motion indicated by a red arrow. The image likely demonstrates how to prepare the medication for injection.*

FDA Label Image

Figure (Lispro Ifu Remove Shield V1)

An instructional diagram showing proper needle shield handling for an injection device. The image illustrates keeping the outer needle shield and discarding the inner needle shield, with corresponding labeled visual representations and a directional arrow.*

FDA Label Image

Figure (Lispro Ifu Twist V1)

An instructional illustration showing a syringe with a cap being removed by twisting and pulling off the cap. A red arrow indicates the direction to twist and remove the needle cap before use.*

FDA Label Image

Figure (Lispro Inj Sites V1)

Illustration showing preferred and alternative injection sites for Insulin Lispro injection solution. Shaded areas indicate the abdomen, front and outer thighs, and the upper buttocks as common subcutaneous injection locations for this medication.*

FDA Label Image

Figure (Lispro Jr Ifu 1 V1)

Insulin Lispro Injection Junior KwikPen label, showing the pen device with a dose window displaying 0 units. The label includes the product name and highlights that it is for single patient use only. The pen device is gray with a red and white label band.*

FDA Label Image

Figure (Lispro Jr Ifu 10 V1)

An instructional illustration showing the dial or dosage window of a pen injector for Insulin Lispro injection solution. The visible numeric scale ranges approximately from 3 to 5 units, with a red arrow pointing at the number 4, indicating the dose setting mechanism.*

FDA Label Image

Figure (Lispro Jr Ifu 11 V1)

An instructional illustration showing a close-up view of a dial with numerical markings from 10 to 0, and a red arrow pointing at the number 11. The dial appears to be part of a device related to dosage measurement or delivery.*

FDA Label Image

Figure (Lispro Jr Ifu 12 V1)

An instructional illustration showing a person injecting a solution into the abdomen using a syringe. The hand holds the syringe angled towards the skin, demonstrating a subcutaneous injection technique.*

FDA Label Image

Figure (Lispro Jr Ifu 13 V1)

An illustration showing a close-up view of an insulin pen dose window with a dosage indicator ranging from 0 to 1 unit. The image highlights the dose selection mechanism on the insulin pen.*

FDA Label Image

Figure (Lispro Jr Ifu 14 V1)

An instructional illustration showing a hand holding a syringe and removing the protective cap from the needle. The arrow indicates the direction of cap removal before injection.*

FDA Label Image

Figure (Lispro Jr Ifu 15 V1)

An instructional illustration depicting a hand holding a syringe with a red ribbon or band wrapped around the needle area. The image appears to demonstrate a technique or caution related to syringe handling for Insulin Lispro injection.*

FDA Label Image

Figure (Lispro Jr Ifu 16 V1)

An instructional illustration showing the removal of a protective cap from an insulin pen injector. A red arrow indicates the direction to pull the cap away from the pen, which is designed for subcutaneous injection of Insulin Lispro, 100 iU/mL, by A-S Medication Solutions.*

FDA Label Image

Figure (Lispro Jr Ifu 2 V1)

An illustrated diagram of Insulin Lispro Injection Junior KwikPen parts identifying components including pen cap with cap clip, rubber seal, cartridge holder, plunger, label with product name, pen body, dose window, dose indicator, and dose knob, used for subcutaneous injection of insulin lispro 100 IU/mL.*

FDA Label Image

Figure (Lispro Jr Ifu 3 V1)

An instructional diagram showing parts of a pen needle assembly and a dose knob. The pen needle parts labeled include the outer needle shield, inner needle shield, needle, and paper tab. A separate image depicts the dose knob component.*

FDA Label Image

Figure (Lispro Jr Ifu 4 V1)

An instructional illustration showing an injection pen-style device with an attached needle cap being removed by pulling it backward, indicated by a red arrow pointing left. The image demonstrates part of the preparation steps for administering an injection.*

FDA Label Image

Figure (Lispro Jr Ifu 5 V1)

An instructional illustration showing a close-up of a syringe barrel with visible volume markings and a red arrow pointing upward, likely indicating the direction for adjusting or preparing the injection volume.*

FDA Label Image

Figure (Lispro Jr Ifu 6 V1)

An instructional illustration showing two hands holding a syringe. One hand grips the syringe barrel while the other hand flicks or taps the side of the syringe near the top, indicating a step to remove air bubbles from the syringe before injection.*

FDA Label Image

Figure (Lispro Jr Ifu 7 V1)

An instructional illustration showing a hand holding a syringe with a plunger being pushed upward, accompanied by a magnified inset highlighting the syringe needle tip. The image appears to demonstrate a technique related to preparing or using an injection.*

FDA Label Image

Figure (Lispro Jr Ifu 8 V1)

Close-up image of part of a medication vial or syringe, showing a measurement scale from 0 to 0.5 units, with a gray cap or plunger visible on the right side. The image likely relates to Insulin Lispro 100 [iU]/mL injection solution by A-S Medication Solutions.*

FDA Label Image

Figure (Lispro Jr Ifu 9 V1)

An instructional illustration showing a close-up of a dosage window on a pen-style injector for insulin lispro. The window displays numbered dosage increments, with an arrow indicating the user should turn or adjust the dial to set the dose before injection.*

FDA Label Image

Figure (Lispro Kp Ifu 1 V3)

Insulin Lispro Injection KwikPen U-100 is shown in this image. The pen injector is blue with a label indicating it is for single patient use only. The label includes the strength U-100 and the brand name Insulin Lispro Injection KwikPen.*

FDA Label Image

Figure (Lispro Kp Ifu 10 V2)

An illustration showing a close-up of a dosing dial on an insulin pen, likely representing the setting of insulin units for injection. The image focuses on the mechanism to select dose increments.*

FDA Label Image

Figure (Lispro Kp Ifu 11 V2)

An illustration showing a close-up of a dosing window on a pen device for insulin injection. The dial displays measurement markings around 8 to 10 units, and a hand is gripping the pen with an arrow indicating an upward motion, likely demonstrating how to adjust or prepare the insulin dose.*

FDA Label Image

Figure (Lispro Kp Ifu 12 V3)

An illustration showing a close-up of a dosage window on an insulin pen, with adjustable numbers visible through the window and a red arrow pointing at the number 12. The pen body is blue with a cap on the right side.*

FDA Label Image

Figure (Lispro Kp Ifu 13 V3)

An instructional diagram showing the dose window of an insulin pen with dose numbers visible through a small window, highlighting the number 26 in red with an arrow pointing to it. The pen is blue and white with a dial showing dose increments.*

FDA Label Image

Figure (Lispro Kp Ifu 16 V2)

An instructional illustration showing a person administering an injection with a syringe into the lower abdominal area just above the waistband of their pants.*

FDA Label Image

Figure (Lispro Kp Ifu 18 V2)

An instructional illustration showing a hand holding an insulin pen injector and removing the protective cap from the needle, as indicated by a red arrow. The image relates to the preparation or administration of insulin injection, likely Insulin Lispro 100 units/mL.*

FDA Label Image

Figure (Lispro Kp Ifu 19 V2)

An instructional illustration showing a hand holding a syringe with a measurement scale from 0 to 180 units. There is a red ribbon-like line coiled outside the syringe tip, possibly representing insulin flow or injection guidance. The syringe is partially covered with a blue sleeve at the rear end.*

FDA Label Image

Figure (Lispro Kp Ifu 2 V3)

An instructional illustration showing the parts of the Insulin Lispro KwikPen injection device. Labels identify the pen cap with cap clip, rubber seal, cartridge holder with insulin cartridge marked 60, 120, 180 units, plunger, label showing Insulin Lispro Injection U-100, pen body, dose indicator, dose window, dose knob, and label indicating 'For Single Patient Use Only.'*

FDA Label Image

Figure (Lispro Kp Ifu 20 V3)

An instructional diagram showing the assembly of a syringe with a blue protective cap being removed by sliding it off, indicated by a red arrow pointing away from the syringe. The syringe barrel includes volume markings.*

FDA Label Image

Figure (Lispro Kp Ifu 2a V1)

An instructional illustration showing the parts of a pen needle, including the outer needle shield, inner needle shield, needle, and paper tab, alongside a separate image of a dose knob. The image is likely related to the use or assembly of insulin injection devices.*

FDA Label Image

Figure (Lispro Kp Ifu 3 V3)

An illustration showing how to remove a blue protective cap from a syringe or pen device by pulling it off in the direction of a red arrow pointing left. This instructional image relates to proper preparation or use of a medication injection device.*

FDA Label Image

Figure (Lispro Kp Ifu 7 V2)

An illustration showing a close-up view of a dosing scale on an injection device, marked with dose units from 1 to 4. A red arrow points upward next to the scale, indicating the direction to increase or adjust the dose. This is related to Insulin Lispro injection, solution.*

FDA Label Image

Figure (Lispro Kp Ifu 8 V2)

An instructional illustration showing a hand holding a vial and another hand adjusting or twisting the cap on the vial, commonly related to preparing insulin lispro injection solution for use.*

FDA Label Image

Figure (Lispro Kp Ifu 9 V2)

An instructional illustration showing a hand holding an insulin injection pen, with an arrow indicating upward movement of the pen's bottom section. A magnified inset highlights a detailed internal mechanism of the pen, likely demonstrating dose setting or injection preparation for Insulin Lispro injection solution.*

FDA Label Image

Figure 1 (Lispro Uspi 1 V2)

A line graph comparing blood glucose levels (mg/dL) over time (minutes) for Insulin Lispro Injection and Humulin R in a 10-subject study with a mean dose of 15.4 units. The x-axis shows time from 0 to 480 minutes, and the y-axis shows blood glucose ranging from 0 to 250 mg/dL.*

FDA Label Image

Figure 2 (Lispro Uspi 2 V2)

A line graph comparing serum free insulin concentration (mU/L) over time (minutes) for Insulin Lispro Injection and Humulin R, both with a sample size of 10, at a mean dose of 15.4 units. The graph shows time on the x-axis and insulin concentration on the y-axis, with Insulin Lispro represented by a dashed line and Humulin R by a solid line.*

FDA Label Image

Figure (Lispro Vial Ifu 1 V2)

Insulin Lispro Injection U-100 in a clear glass vial with a black protective cap and an under-cap rubber stopper. The label indicates it is for Rx only, with the manufacturer listed as Lilly. The vial is used for subcutaneous or intravenous injection.*

FDA Label Image

Figure (Lispro Vial Ifu 10 V1)

Illustration showing the correct technique to draw insulin lispro solution from a vial into a syringe, with a close-up of the syringe barrel marked from 10 to 40 units. The image emphasizes proper handling for injection preparation.*

FDA Label Image

Figure (Lispro Vial Ifu 11 V1)

Instructional illustration showing a hand holding a vial and another hand holding a syringe. An arrow indicates drawing liquid from the vial into the syringe, demonstrating how to prepare an injection dose.*

FDA Label Image

Figure (Lispro Vial Ifu 13 V1)

An instructional illustration showing a person receiving an injection in the abdominal area. The image depicts a hand holding a syringe angled toward the lower abdomen near the waistband, indicating subcutaneous injection technique.*

FDA Label Image

Figure (Lispro Vial Ifu 14 V1)

Illustration showing a hand administering an injection into the abdomen area, demonstrating subcutaneous injection technique appropriate for insulin delivery.*

FDA Label Image

Figure (Lispro Vial Ifu 15 V1)

An instructional illustration depicting a hand holding a syringe with a needle inserted into the side of a person's neck area, demonstrating the administration technique for an injection near the neck region.*

FDA Label Image

Figure (Lispro Vial Ifu 2 V2)

An instructional illustration of a syringe with labeled parts including needle shield, needle, plunger tip, syringe body, and plunger. The image highlights the syringe scale with an example dose of 20 units marked at the plunger tip, demonstrating proper dose measurement.*

FDA Label Image

Figure (Lispro Vial Ifu 3 V1)

An instructional illustration showing a hand removing the cap from a small vial, likely depicting preparation steps for administering Insulin Lispro injection solution. The vial is held upright, and an arrow indicates the direction to pull off the cap.*

FDA Label Image

Figure (Lispro Vial Ifu 4 V1)

An illustration showing hands preparing a vial, likely demonstrating how to use or handle the insulin lispro injection solution vial.*

FDA Label Image

Figure (Lispro Vial Ifu 5 V1)

An instructional illustration showing a hand holding a syringe vertically with the needle inserted into a vial. Another hand holds the vial steady, and a downward arrow indicates pushing the syringe into the vial. A close-up inset shows the syringe barrel with volume markings, highlighting a fluid level near 10 mL.*

FDA Label Image

Figure (Lispro Vial Ifu 6 V1)

An instructional illustration showing a hand holding a vial and a syringe being inserted into the vial. An arrow indicates the direction of the syringe entering the vial, suggesting the process of drawing medication from the vial for injection.*

FDA Label Image

Figure (Lispro Vial Ifu 7 V1)

An instructional illustration showing a person drawing insulin solution from a vial into a syringe. The right hand holds the syringe, while the left hand stabilizes the vial. An arrow indicates the direction of syringe plunger movement during the withdrawal process.*

FDA Label Image

Figure (Lispro Vial Ifu 8 V1)

An instructional illustration depicting a hand holding a vial with a needle inserted into it and a syringe attached, showing the process of drawing insulin. An inset zooms in on the syringe barrel marked with graduated measurement lines up to 40 units, indicating dosage measurement.*

FDA Label Image

Figure (Lispro Vial Ifu 9 V1)

An instructional illustration depicting a hand holding a vial and a syringe, demonstrating the process of drawing up medication. The left hand holds the vial upside down, while the right hand holds the syringe, with the needle inserted into the vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.